Smart Money Is Betting Big In NVO Options
Unusual Options Activity: LRCX, COIN and Others Attract Market Bets, LRCX V/OI Ratio Reaches 119.0
EU Antitrust Regulators Expected to Approve Novo Holdings' $16.5B Acquisition of Catalent Without Conditions
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
novo-nordisk a/s (NVO.US) has signed a contract with Ypsomed to produce the next generation of injection pens for weight loss medication.
novo-nordisk a/s has announced that it has signed a contract with Ypsomed to produce the next generation of weight loss pen.
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
PrayHardToEarnMoney : boss bring me fly
Chris gogo : Wise enough, I will try to buy at 99 if possible![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")